Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetic mellitus patients: A double-blind randomised clinical trial

Singapore Medical Journal

Volumn 54, Issue 7, 2013, Pages 387-390

  Sarbolouki, Shokouh ^a   Javanbakht, Mohammad Hassan ^a   Derakhshanian, Hoda ^a   Hosseinzadeh, Payam ^a   Zareei, Mahnaz ^a   Hashemi, Seyed Behnam ^a   Dorosty, Ahmad Reza ^a   Eshraghian, Mohammad Reza ^a   Djalali, Mahmoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Eicosapentaenoic acid; Insulin sensitivity

Indexed keywords

CORN OIL; GLUCOSE; HEMOGLOBIN; ICOSAPENTAENOIC ACID; INSULIN; PLACEBO; PLUS EPA; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OVERWEIGHT; PLACEBOS; TREATMENT OUTCOME;

EID: 84880617689     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2013139     Document Type: Article

References (28)

1. International Diabetes Federation. Diabetes Atlas. Belgium: IDF, 2000.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.
4. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-412.
5. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 2005; 105:428-440.
6. Sirtori CR, Crepaldi G, Manzato E, et al. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycaemic alterations. Atherosclerosis 1998; 137:419-427.
7. Borkman M, Chisholm DJ, Furler SM, et al. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 1989; 38:1314-1319.
8. Vessby B. N-3 fatty acids and blood glucose control in diabetes mellitus. J Intern Med Suppl 1989; 731:207-10.
9. Axelrod L, Camuso J, Williams E, et al. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double33 blind, controlled study. Diabetes Care 1994; 17:37-44.
10. Browning LM, Krebs JD, Moore CS, et al. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007; 9:70-80.
11. Navas-Carretero S, Pérez-Granados AM, Schoppen S, Vaquero MP. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr 2009; 102:546-553.
12. Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self management education. Diabetes Care 2012; 35 suppl 1:S101-S108.
13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
14. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-10.
15. Kaushik M, Mozaffarian D, Spiegelman D, et al. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 2009; 90:613-20.
16. Heine RJ. Dietary fish oil and insulin action in humans. Ann N Y Acad Sci 1993; 683:110-121.
17. Connor WE, Prince MJ, Ullmann D, et al. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann N Y Acad Sci 1993; 683:337-340.
18. Mori TA, Bao DQ, Burke V, et al. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999; 70:817-825.
19. Egert S, Fobker M, Andersen G, et al. Effects of dietary-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on parameters of glucose metabolism in healthy volunteers. Ann Nutr Metab 2008; 53:182-187.
20. Mahmoudabadi MM, Djalali M, Djazayery SA, et al. Effects of eicosapentaenoic acid and vitamin C on glycaemic indices, blood pressure, and serum lipids in type 2 diabetic Iranian males. J Res Med Sci 2011; 16 suppl 1:S361-367.
21. Griffin MD, Sanders TA, Davies IG, et al. Effects of altering the 1 ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006; 84:1290-1298.
22. Rasic-Milutinovic Z, Perunicic G, Pljesa S, et al. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 2007; 29:321-329.
23. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83 (6 suppl):1505S-1519S.
24. Lichtenstein AH, Schwab US. Relationship of dietary fat to glucose metabolism. Atherosclerosis 2000; 150:227-243.
25. Nugent C, Prins JB, Whitehead JP, et al. Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 2001; 276:9149-9157.
26. Figueras M, Olivan M, Busquets S, López-Soriano FJ, Argilés JM. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity (Silver Spring) 2011; 19:362-369.
27. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56:1198-1209.
28. Rosenson RS. Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus. Am J Cardiol 2007; 99:96B-104B.